Bioventus launches OSTEOMATRIX biphasic bone graft

396

 

OSTEOMATRIX+ (Bioventus)

Bioventus has launched OSTEOMATRIX+, a biphasic bone graft for use in bone remodelling in a variety of orthopaedic and spine applications. OSTEOMATRIX+ is a mouldable bone graft substitute consisting of bovine collagen and biphasic, hydroxyapatite/ß-tricalcium phosphate granules designed to produce a porous scaffold and sustained osteoconductivity throughout the bone remodelling process.

The Bioventus research and development group led a cross functional team to develop OSTEOMATRIX+ which has more unique handling properties, including improved mouldability, flexibility and versatility, than its predecessor.

OSTEOMATRIX+ is a bone graft substitute intended for use in bony voids or gaps of the skeletal system not intrinsic to the stability of the bony structure. These osseous defects may be surgically created or result from traumatic injury to the bone.

The biphasic bone graft is indicated to be combined with autologous bone marrow aspirate and packed into osseous defects of the extremities, pelvis and posterolateral spine. When used in the posterolateral spine, OSTEOMATRIX+ is to be used as an autograft extender. The device resorbs and is replaced by host bone during the healing process.

(Visited 95 times, 1 visits today)

LEAVE A REPLY

Please enter your comment!
Please enter your name here